First person dies from mysterious vaping illness as nearly 200 people report breathing problems

193 e-cigarette smokers in 22 US states suffering respiratory issues

Matt Richtel,Sheila Kaplan
Saturday 24 August 2019 16:18
Comments
Mystery lung illness linked to vaping reported in nearly 100 people

A patient has became the first to die of a mysterious lung illness linked to vaping, public health officials in Illinois have announced.

The death occurred as doctors and hospitals across the US report an increasing number of vaping-related respiratory illnesses this summer.

A total of 193 cases have been reported in 22 states, including 22 cases in Illinois, officials say.

They have been stumped in recent weeks by the cause. State investigators have not found a common link – other than vaping in general – among the patients turning up in emergency rooms.

Many patients have acknowledged vaping tetrahydrocannabinol, or THC, the high-inducing chemical in marijuana, according to statements from federal and state health agencies.

But officials don’t know whether the ailments have been caused by marijuana-type products, e-cigarettes, by vaping some type of street concoction, or whether a contaminant or defective device may have been involved.

The Illinois patient’s death was disclosed during a news conference held by officials at the US Centres for Disease Control and Prevention, the Food and Drug Administration (FDA) and the state of Illinois.

They did not provide details about the patient’s identity, saying only that the person was an adult who had vaped recently and then succumbed to a severe respiratory illness.

Health officials did not say what product the patient had used, whether an e-cigarette or other vaping device; nor did they specify what substance had been vaped.

Amid the lack of information, investigators are scrambling to find shared links to the respiratory problems.

Officials said this week that many patients, most of whom were adolescents or young adults, had described difficulty breathing, chest pain, vomiting and fatigue.

The most seriously ill patients have had extensive lung damage that has required treatment with oxygen and days on a ventilator. Some are expected to have permanent lung damage.

“We’re at a relatively early stage of understanding,” Mitchell Zeller, director for the Centre for Tobacco Products at the FDA, said.

The collective agencies were throwing “a lot of resources at this”, he added, but part of the problem was that state investigations are not always complete, making it difficult to form a clear picture.

The New York Times

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in